ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)

About Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Details

Daily high

$247.10

Daily low

$237.96

Price at open

52 Week High

$495.55

52 Week Low

$197.81

Market cap

32.1B

Dividend yield

Volume

363

Avg. volume

1.7M

P/E ratio

40.45

Alnylam Pharmaceuticals, Inc. - Common Stock News